About   Help   FAQ
Phenotypes associated with this allele
Allele Symbol
Allele Name
Allele ID
Cd38tm1Lnd
targeted mutation 1, Frances E Lund
MGI:1861803
Summary 4 genotypes


Genotype
MGI:3723582
hm1
Allelic
Composition
Cd38tm1Lnd/Cd38tm1Lnd
Genetic
Background
B6.129P2-Cd38tm1Lnd
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Cd38tm1Lnd mutation (4 available); any Cd38 mutation (53 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
endocrine/exocrine glands
• islets are significantly more susceptible to apoptosis at physiological glucose concentrations, in the presences of palmitate, or in the absence of serum
• small but significant decrease in beta cell mass is observed under normal diet and high-fat feeding relative to controls
• disrupted islet architecture is observed
• glucagon-containing alpha cells are distributed diffusely between beta cells, whereas in wild-type islets, alpha cells are exclusively in the islet mantle

homeostasis/metabolism
N
• blood glucose is not significantly different from wild-type regardless of diet
• glucose tolerance does not differ significantly, but there is a trend toward higher 30-minute glucose values in female mutants on both normal and high-fat diets
• insulin tolerance is similar to wild-type on both normal and high-fat diets
• significant insulin resistance is observed in mice fed a high-fat diet

cellular
• islets are significantly more susceptible to apoptosis at physiological glucose concentrations, in the presences of palmitate, or in the absence of serum




Genotype
MGI:2662016
hm2
Allelic
Composition
Cd38tm1Lnd/Cd38tm1Lnd
Genetic
Background
involves: 129P2/OlaHsd * C57BL/6J
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Cd38tm1Lnd mutation (4 available); any Cd38 mutation (53 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
immune system
• in response to immunization with the TD antigen TNP(5)-KLH in alum adjuvant, mutants exhibit decreased hapten-specific IgM, IgG1, and IgE responses but mount normal hapten-specific IgG2a, IgG2b, IgG3 and IgA responses, however when mutants are immunized with TNP(5)-KLH in Freund's adjuvant, primary antibody responses are not different from wild-type
• mutants fail to mount significant secondary hapten-specific antibody responses
• mutants show elevated antibody responses to the TI-2 antigen alpha1-3 dextran but not to NP(27)-Ficoll

homeostasis/metabolism
• NAD+ glycohydrolase activity in the spleen is reduced to less than 1% of the activity seen in wild-type spleens and no activity is detected in the liver and brain




Genotype
MGI:3623958
hm3
Allelic
Composition
Cd38tm1Lnd/Cd38tm1Lnd
Genetic
Background
NOD.129P2(B6)-Cd38tm1Lnd/LtJ
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Cd38tm1Lnd mutation (4 available); any Cd38 mutation (53 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
immune system
• Cd38-deficient NOD mice display higher NAD-mediated T cell death
• insulitis progression in null NOD mice is accelerated at 9 weeks or later compared to wild-type NOD mice
• homozygous NOD mutants show significant acceleration in diabetes development compared to wild-type NOD mice; the first diagnosis of diabetes is made at 10 weeks of age while in wild-type NOD mice it occurs at 12 weeks or later; the frequency in null NOD males is 100% by 28 weeks which is higher than the frequency in wild-type NOD males
• diabetes acceleration is seen only when Cd38-deficient bone marrow from NOD mice is transferred to Cd38-deficient recipients
• diabetes onset is assessed by 2 consecutive positive urine glucose tests

endocrine/exocrine glands
• insulitis progression in null NOD mice is accelerated at 9 weeks or later compared to wild-type NOD mice

cellular
• Cd38-deficient NOD mice display higher NAD-mediated T cell death

hematopoietic system
• Cd38-deficient NOD mice display higher NAD-mediated T cell death

Mouse Models of Human Disease
DO ID OMIM ID(s) Ref(s)
type 1 diabetes mellitus DOID:9744 OMIM:222100
J:108097




Genotype
MGI:3623961
cx4
Allelic
Composition
Art2atm1Fkn/Art2atm1Fkn
Art2btm1Fkn/Art2btm1Fkn
Cd38tm1Lnd/Cd38tm1Lnd
Genetic
Background
NOD.129(B6)-Cd38tm1Lnd Art2atm1Fkn Art2btm1Fkn/Lt
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Art2atm1Fkn mutation (2 available); any Art2a mutation (9 available)
Art2btm1Fkn mutation (3 available); any Art2b mutation (23 available)
Cd38tm1Lnd mutation (4 available); any Cd38 mutation (53 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
immune system
• double knockout NOD mice exhibit strong protection from diabetes in both sexes; female knockouts acquire diabetes at a frequency of 25% by 28 weeks compared to 100% in Cd38-null NOD females; double knockout NOD males are completely protected at 28 weeks compared to 100% incidence in Cd38-null NOD males





Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support.
last database update
11/12/2024
MGI 6.24
The Jackson Laboratory